Himedia Chemicals Gallic Acid India

Lab Reagents

Himedia Chemicals Laboratories manufactures the himedia chemicals gallic acid india reagents distributed by Genprice. The Himedia Chemicals Gallic Acid India reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact himedia chemicals. Other Himedia products are available in stock. Specificity: Himedia Category: Chemicals Group: Gallic Acid

Gallic Acid information

IAV H5N1 H5 (aa 17-530) (A/chicken/India/NIV33487/2006) [His]

DAG1791 50 ug
EUR 1681

IAV H5N1 Hemagglutinin (aa 17-530) (A/chicken/India/NIV33487/2006 ) [His]

DAG2172 100 µg
EUR 913

IAV H9N2 Hemagglutinin 1 (aa 16-335) (A/chicken/India/IVRI-0011/2011) [His]

DAG2251 100 µg
EUR 913

Octanoic acid (Caorylic acid)

O5678 250ml
EUR 67.4

Okadaic acid, free acid

OL1198 50ug
EUR 192.68

Fumalic acid(Ferulic acid)

E1KS2300 50mg
EUR 325

Recombinant IAV H5N1 Hemagglutinin / HA Protein (aa 1-529) [His] (A/chicken/India/NIV33487/06)

VAng-Wyb7157-100g 100 µg
EUR 1741
Description: Influenza A H5N1 (A/chicken/India/NIV33487/06) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H5N1 Hemagglutinin / HA Protein (aa 1-529) [His] (A/chicken/India/NIV33487/06)

VAng-Wyb7157-50g 50 µg
EUR 1050
Description: Influenza A H5N1 (A/chicken/India/NIV33487/06) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H5N1 Hemagglutinin / HA Protein (aa 1-531) [His] (A/chicken/India/NIV33487/06)

VAng-Wyb7158-100g 100 µg
EUR 1741
Description: Influenza A H5N1 (A/chicken/India/NIV33487/06) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H5N1 Hemagglutinin / HA Protein (aa 1-531) [His] (A/chicken/India/NIV33487/06)

VAng-Wyb7158-10g 10 µg
EUR 573
Description: Influenza A H5N1 (A/chicken/India/NIV33487/06) Hemagglutinin / HA, recombinant protein.

Recombinant IAV H5N1 Hemagglutinin / HA Protein (aa 1-531) [His] (A/chicken/India/NIV33487/06)

VAng-Wyb7158-50g 50 µg
EUR 1050
Description: Influenza A H5N1 (A/chicken/India/NIV33487/06) Hemagglutinin / HA, recombinant protein.

SARS-CoV-2 (COVID-19) Full-Length Kappa Variant (B.1.617.1, India) Spike Recombinant Protein

21-823 0.025 mg
EUR 663.5
Description: All viruses undergo fast mutations and adapt quickly to the countermeasures that the immune systems creates. SARS-CoV-2 of the COVID-19 pandemic is no exception to this. During the pandemic multiple mutant strains arose. To help the sciencific community to combat these mutants ProSci offers the SPIKE protein of the mutants in full-length and active in their native trimeric form, stabilized with the LMNG detergent. This is the spike protein of the mutant strain B.1.429, also known as mutant strain CAL.20C or "California mutant".

DL-Maleic acid (Toxilic acid)

MA0333 250g
EUR 64.5

D-Glucuronic acid, free acid

GB0482 5g
EUR 155.16

Recombinant IAV H5N1 Hemagglutinin HA1 Subunit Protein (aa 1-340) [His] (A/chicken/India/NIV33487/06)

VAng-Wyb7159-100g 100 µg
EUR 1741
Description: Influenza A H5N1 (A/chicken/India/NIV33487/06) Hemagglutinin HA1 Subunit, recombinant protein.

Recombinant IAV H5N1 Hemagglutinin HA1 Subunit Protein (aa 1-340) [His] (A/chicken/India/NIV33487/06)

VAng-Wyb7159-50g 50 µg
EUR 1050
Description: Influenza A H5N1 (A/chicken/India/NIV33487/06) Hemagglutinin HA1 Subunit, recombinant protein.

SARS-CoV-2 (COVID-19) Kappa Variant (B.1.617, India) Spike RBD (E484Q, L452R) Recombinant Protein

20-185 0.1 mg
EUR 595.25
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.